期刊文献+

局部晚期乳腺癌有效新辅助化疗后病灶的病理表现及保乳可行性分析 被引量:4

Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer
原文传递
导出
摘要 目的探讨局部晚期乳腺癌经新辅助化疗后病灶消退的病理表现及肿块缩小后保乳手术的可行性。方法回顾分析2003年6月至2007年8月46例有效的新辅助化疗后手术的乳腺癌患者的临床资料。患者均为女性,年龄28~65岁,平均46.3岁,肿瘤最大径7—13cm。所有病例均在新辅助化疗后行乳腺癌改良根治术或标准根治术,术后对切除标本以残余肿瘤为中心行6个不同方向的连续切片,评价肿瘤的消退情况。结果全组41.3%(19/46)肿瘤呈向心性缩小,其中31.6%(6/19)肿瘤向心性缩小并且周围无癌灶残留,68.4%(13/19)肿瘤向心性缩小但周围仍有癌灶残留。全组58.7%(27/46)肿瘤呈筛状消退。结论局部晚期乳腺癌经新辅助化疗有效的大部分患者病理表现仍未达到保乳要求,保乳手术应慎重。 Objective To investigate the pathological manifestation of the lesion as well as the feasibility of conservative breast surgery after neoadjuvant chemotherapy of patients with locally advanced breast cancer. Methods Clinic data of the 46 patients treated by neoadjuvant chemotherapy effectively and surgical procedures from June 2003 to August 2007 were analyzed. All the patients were female, aged from 28 to 65 years old with a mean of 46. 3 years old. The diameter of neoplasm was 7 to 13 cm. All the patients had been treated by neoadjuvant chemotherapy effectively and received modified radical mastectomy or Halsted radical masteetomy. The specimen slices were cut from 6 different directions taking the residual cancerous lesion as the center. Results Nineteen patients(41.3% ) were concentrating contracted, with eomplete remission in 6 patients(31.6% ) and residual focus in peripheral zone in 13 patients(68.4% ). Twenty-seven patients (58.7%) responded in a sifter-like pattern. Conclusion For most patients with locally advaneed breast cancer treated by neoadjuvant chemotherapy effectively, their pathologic features are not up to the conservative breast surgery criterion, conservative breast surgery should be cautiously considered.
出处 《中华外科杂志》 CAS CSCD 北大核心 2008年第18期1394-1396,共3页 Chinese Journal of Surgery
基金 湖北省卫生厅科研基金资助项目(JX3857)
关键词 乳腺肿瘤 抗肿瘤联合化疗方案 病理学 外科 Breast neoplasms Antineoplastic combined chemotherapy protocols Pathology, surgical
  • 相关文献

参考文献5

  • 1Coudert BP,Largillier R, Amould L, et al. Multicenter phase Ⅱ trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2- overexpressing stage Ⅱ or Ⅲ breast cancer:resuhs of the GETN (A) -1 trial. J Clin Oncol,2007 ,25 :2678-2684.
  • 2Sachelarie I, Grossbard ML, Chadha M, et al. Primary systemic therapy of breast cancer. Oncologist,2006,11:574-589.
  • 3Vyzula R,Dusek L, Zaloudik J, et al. Breast cancer and neoadjuvant therapy : any predictive marker? Neoplasma, 2004, 51:471480.
  • 4周波,杨德启,乔新民,佟富中,曹迎明,刘鹏,刘宏军.可手术乳腺癌新辅助化疗后保乳手术的可行性研究[J].中华医学杂志,2005,85(11):769-772. 被引量:13
  • 5Tozaki M,Kobayashi T, Uno S, et al. Breast-conserving surgery after chemotherapy: value of MDCT for determining tumor distribution and shrinkage pattern. AJR Am J Roentgenol,2006, 186:431-439.

二级参考文献10

  • 1周波,佟富中,杨德启,曹迎明,刘鹏,刘宏军,乔新民,张嘉庆.表阿霉素联合紫杉醇的新辅助化疗治疗乳腺癌的临床观察[J].中国妇产科临床杂志,2002,3(1):30-32. 被引量:5
  • 2Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomized trials on 1973 patients. Eur J Cancer, 1995,31A:1574-1579.
  • 3Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol, 1998,16:2672-2685.
  • 4Singletary SE,Mcneese MD,Hortobagyi GN.Feasibility of breast- conservation surgery after induction chemotherapy for locally advanced breast carcinoma.Cancer, 1992,69:2849-2852.
  • 5Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer, 1994,73:362-369.
  • 6Minckwitz G, Costa SD, Eiermann W,et al.Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol, 1999,17:1999-2005.
  • 7Smith I, Heys S, Hutcheon A,et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.J Clin Oncol, 2002,20:1456-1466.
  • 8Fisher B,Brown A,Mamounas E,et al.Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer:finding from national surgical adjuvant breast and bowel project B-18.J Clin Oncol, 1997,15:2483-2493.
  • 9Veronesi U,Bonadonna G,Zurrida S,et al.Conservation surgery after primary chemotherapy in large carcinomas of the breast.Ann Surg ,1995,222:612-618.
  • 10Kuerer HM,Singletary SE,Buzdar AU,et al.Surgical conservation planning after neoadjuvant chemotherapy for stage Ⅱ and operable stage Ⅲ breast carcinoma. Am J Surg ,2001,182:601-608.

共引文献12

同被引文献34

  • 1张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:246
  • 2周丽菲,朱忆凌,黄渊,吕益新.病理大切片制作及其诊断价值[J].临床与实验病理学杂志,2006,22(1):100-100. 被引量:5
  • 3秦贤举,陈君雪,张宏伟,赵大方,张华,罗文杰,黄倩,练士贤,童汉兴.216例女性乳腺癌保乳手术及综合治疗的临床分析[J].临床肿瘤学杂志,2006,11(7):521-524. 被引量:15
  • 4Piccart MJ, Kerger J, Tomiak E, et al.Systemic treatment for locally advanced breast cancer:what we still need to learn after a decade of multimodality clinical trials[J].Eur J Cancer, 1992, 28(2-3):667-672.
  • 5Fisher B, Bryant J, Wolmark N, et al.Effect of preopera- tive chemotherapy on the outcome of women with operable breast cancer[J].J Clin Oncol, 1998, 16(8):2672-2685.
  • 6Bear HD, Anderson S, Brown A, et al.The effect on tu- mor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide:pre- liminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J].J Clin Oncol, 2003, 21 (22):4165-4 174.
  • 7Smith IC, Heys SD, Hutcheon AW, et al.Neoadjuvant chemotherapy in breast cancer:significantly enhanced response with docetaxel [J].J Clin Oncol, 2002, 20(6): 1456-1466.
  • 8Sachelarie I, Grossbard ML, Chadha M, et al.Primary systemic therapy of breast cancer[J].Oncologist, 2006, 11 (6):574-589.
  • 9Fitzal F, Riedl O, Mittlbfick M, et al.Oncologic safety of breast conserving surgery after tumor downsizing by neoadjuvant therapy: a retrospective single centre cohort study [J]. Breast Cancer Res Treat, 2011,127(1):121-128.
  • 10Rajan R, Poniecka A, Smith TL, et al.Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response[J].Cancer, 2004, 100(7):1365-1373.

引证文献4

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部